General MedicationsINJECTIONStandard
TRAZIMERA
TRASTUZUMAB-QYYP
Standard Dose
420MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TRAZIMERA is listed in Drugs@FDA under application 761081 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TRASTUZUMAB-QYYP Form and strength INJECTABLE;INJECTION - 420MG Sponsor PFIZER INC Submission history Latest submission status date: 2025-08-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRAZIMERA is listed in Drugs@FDA under application 761081 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRASTUZUMAB-QYYP Form and strength INJECTABLE;INJECTION - 420MG Sponsor PFIZER INC Submission history Latest submission status date: 2025-08-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.